z-logo
open-access-imgOpen Access
Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture
Author(s) -
Riley L. Svec,
Sydney A. McKee,
Matthew R. Berry,
Aya M. Kelly,
Timothy M. Fan,
Paul J. Hergenrother
Publication year - 2022
Publication title -
acs chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.899
H-Index - 111
eISSN - 1554-8937
pISSN - 1554-8929
DOI - 10.1021/acschembio.2c00022
Subject(s) - temozolomide , cancer research , methyltransferase , prodrug , o 6 methylguanine dna methyltransferase , dna repair , drug resistance , cancer , pharmacology , medicine , oncology , glioma , biology , dna , biochemistry , genetics , methylation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom